Ye-Su Chao

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Great Novel Therapeutics Biotech & Medicals Corporation, Gnt Biotech & Medicals Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ye-Su Chao. Retrieved from https://idiyas.com/inventor/ye-su-chao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

4 out of 4

Great Novel Therapeutics Biotech & Medicals Corporation

patents

1 out of 2

Gnt Biotech & Medicals Corporation

patents

Years Active: 2020-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12213971 - Histone deacetylase inhibitors for immunomodulation in tumor microenvironment (2025-02-04),

2. 11878009 - Anticancer combination of chidamide and celecoxib salts (2024-01-23),

3. 11840570 - Pharmaceutical combination and method for regulation of tumor microenvironment and immunotherapy (2023-12-12),

4. 11672788 - Histone deacetylase inhibitors for immunomodulation in tumor microenvironment (2023-06-13),

5. 10688193 - PH-sensitive linkers for delivering a therapeutic agent (2020-06-23),

I specialize only in this one: innovations, inventions, inventors, patent attorneys, assignees and patents.

Profile summary based on public USPTO records.